cell
surfac
glycoconjug
present
alter
structur
chronic
diseas
distinct
oligosaccharid
epitop
associ
cancer
among
truncat
glycan
present
termin
nonreduc
glcnac
residu
rare
healthi
tissu
lectin
unconvent
sourc
fungi
algi
provid
novel
marker
bind
specif
epitop
avail
may
challeng
glcnacbind
lectin
fruit
bodi
fungu
psathyrella
velutina
pvl
produc
good
yield
bacteri
cultur
strong
specif
termin
glcnac
residu
evidenc
glycan
array
affin
valu
obtain
microcalorimetri
surfac
plasmon
reson
demonstr
micromolar
affin
epitop
biantennari
nglycan
cap
branch
crystal
structur
pvl
complex
establish
structur
basi
specif
label
sever
type
cancer
cell
use
inhibitor
glycan
metabol
indic
rpvl
bind
termin
glcnac
also
sialic
acid
analysi
glycosyltransferas
express
confirm
higher
amount
glcnac
present
cancer
cell
rpvl
bind
specif
cancer
tissu
weak
label
observ
healthi
one
except
stomach
gland
present
uniqu
mucin
lung
breast
colon
carcinoma
clear
delin
could
observ
cancer
region
surround
healthi
tissu
pvl
therefor
use
tool
label
agalactoglycan
cancer
diseas
chang
cell
surfac
glycosyl
known
associ
larg
number
chronic
diseas
cancer
glycan
repres
promis
field
biomark
discoveri
glcnac
purchas
sigmaaldrich
disaccharid
lactontetraos
lactontrios
chitobios
chitopentaos
purchas
elicityl
croll
franc
sialidas
clostridium
perfringen
purchas
sigmaaldrich
ref
new
england
biolab
ipswich
f
streptomyc
plicatu
purchas
new
england
biloab
biotinlabel
sialic
acidspecif
lectin
mah
purchas
vector
lab
burlingam
ca
nonasaccharid
azid
fig
prepar
egg
yolk
follow
enzymat
hydrolysi
azid
mg
nonasaccharid
disolv
phosphat
buffer
mm
ph
mm
mgcl
unit
lyophil
ec
ad
solut
mixtur
incub
day
tlc
ammonium
acet
lyophil
residu
purifi
gel
filtrat
superdex
x
cm
nh
hco
ml
min
peak
elut
min
lyophil
desalt
gel
filtrat
sephadex
x
cm
ethanol
water
ml
min
peak
elut
min
lyophil
yield
mg
heptasaccharid
nucleotid
sequenc
code
peptid
sequenc
lectin
fruit
bodi
mushroom
p
velutina
genbank
access
number
supplement
ntermin
posit
aminoacid
msvvvi
synthes
codon
optim
express
escherichia
coli
genscript
piscataway
nj
introduc
express
vector
use
ndei
xhoi
restrict
site
vector
transform
e
coli
novagen
cell
harbor
plasmid
grown
lb
broth
contain
ml
ampicillin
reach
cell
cultur
h
addit
mm
centrifug
x
g
min
bacteria
resuspend
equilibr
buffer
mm
tri
hcl
ph
mm
nacl
broken
cell
disrupt
pressur
kilobar
constant
system
ltd
centrifug
x
g
min
filtrat
affin
chromatographi
glcnacagaros
column
ey
laboratori
inc
perform
supernat
rpvl
allow
bind
immobil
glcnac
equilibr
buffer
wash
mmtrishcl
ph
nacl
elut
mm
free
glcnac
equilibr
buffer
purifi
protein
dialyz
extens
ultrapur
water
day
freezedri
store
purifi
rpvl
label
alexa
fluor
invitrogen
accord
manufactur
instruct
repurifi
dsalt
polyacrylamid
desalt
column
pierc
alexalabel
rpvl
use
glycan
array
screen
standard
procedur
proteinglycan
interact
core
h
consortium
function
glycom
thermal
shift
assay
perform
use
mini
opticon
real
time
pcr
machin
biorad
laboratori
mg
ml
protein
dilut
mm
nacl
mm
tri
ph
cacl
without
oligosaccharid
total
reaction
volum
sypro
orang
molecular
probe
ca
use
fluoresc
probe
detect
nm
temperatur
rais
use
step
fluoresc
read
taken
interv
posit
valu
indic
ligand
stabil
protein
denatur
therefor
bind
protein
minimum
two
independ
measur
perform
condit
recombin
lyophil
rpvl
dissolv
buffer
mm
trishcl
ph
nacl
mm
cacl
degass
protein
concentr
check
measur
use
theoret
molar
extinct
coeffici
cm
carbohydr
ligand
dissolv
buffer
degass
load
inject
syring
itc
perform
microcalorimet
ge
healthcar
rpvl
solut
place
sampl
cell
titrat
perform
inject
carbohydr
ligand
everi
experiment
data
fit
theoret
titrat
curv
use
origin
softwar
suppli
ge
healthcar
enthalpi
chang
ka
associ
constant
n
number
bind
site
per
monom
adjust
paramet
free
energi
chang
entropi
contribut
deriv
equat
rt
ln
ka
absolut
temperatur
r
j
mol
k
two
independ
titrat
perform
test
ligand
spr
experi
perform
biacor
instrument
ge
healthcar
hb
mm
hepesnaoh
ph
mm
nacl
tween
supplement
cacl
flow
rate
min
bind
measur
reson
unit
time
blank
subtract
data
evalu
use
biacor
evalu
softwar
version
dissoci
constant
determin
plot
respons
equilibrium
req
end
inject
analyt
concentr
protein
coat
chip
reson
unit
rpvl
ml
mm
acet
buffer
ph
immobil
flow
channel
research
grade
chip
use
standard
amin
coupl
procedur
flow
channel
activateddeactiv
experi
consist
inject
associ
dissoci
variou
concentr
oligosaccharid
fold
cascad
dilut
channel
crystal
rpvl
complex
obtain
hang
drop
lyophil
protein
dissolv
mg
ml
mm
hepesnaoh
buffer
ph
nacl
mm
cacl
incub
mm
room
temperatur
prior
cocrystal
one
big
rectangularlik
crystal
obtain
sodium
format
diammonium
phosphat
sever
month
one
piec
directli
mount
cryoloop
flashfreez
liquid
nitrogen
diffract
data
collect
k
european
synchrotron
radiat
facil
grenobl
franc
station
use
adsc
ccd
detector
data
process
use
xd
comput
perform
use
suit
data
qualiti
statist
summar
tabl
molecular
replac
techniqu
use
solv
structur
phaser
coordin
nativ
pvl
protein
data
bank
code
structur
refin
restrain
maximum
likelihood
refin
use
refmac
iter
manual
rebuild
coot
incorpor
ligand
perform
inspect
mfodfc
weight
map
water
molecul
introduc
automat
use
coot
inspect
manual
stereochem
qualiti
model
assess
program
molprob
coordin
deposit
protein
data
bank
code
human
nonsmal
cell
lung
cancer
nsclc
bronchial
epitheli
breast
cancer
ovarian
cancer
prostat
cancer
skin
squamou
cell
carcinoma
melanoma
colon
cancer
cell
line
obtain
american
type
cultur
collect
atcc
manassa
va
melanoma
cell
line
gift
dr
nathali
inserm
nant
franc
cell
maintain
medium
gibco
cergi
pontois
franc
except
grown
dmem
g
l
glucos
gibco
maintain
keratinocytesfm
medium
gibco
cultur
media
supplement
heatinactiv
fetal
bovin
serum
cell
kept
humidifi
atmospher
cell
trypsin
aliquot
wash
twice
pb
ca
mg
incub
ml
cell
wash
twice
analysi
perform
accuri
flow
cytomet
use
cflowplu
softwar
bd
bioscienc
altern
biotinyl
rpvl
mah
use
follow
streptavidinphycoerythrin
bd
analysi
perform
facscalibur
cellquest
softwar
bd
indic
cell
preteat
sialidas
sigma
cell
seed
well
plate
treat
differ
glycosyl
inhibitor
fucosyl
transferas
inhibitor
fucos
sialyltransferas
inhibitor
acid
describ
recent
treatment
perform
day
respect
medium
replac
inhibitor
ad
day
order
investig
type
glycosyl
ligand
recogn
rpvl
use
kifunensin
sigma
block
er
consequ
process
nglycan
deoxyalphadgalactopyranosid
benzylgalnac
sigma
block
oglycosyl
process
ppmp
avanti
polar
lipid
alabast
usa
inhibit
synthesi
glycolipid
cell
treat
kifunensin
day
benzylgalnac
ppmp
cell
left
contact
inhibitor
mm
respect
period
medium
chang
cell
incub
day
analysi
ppmp
dilut
dmso
pure
dmso
ad
medium
control
well
order
dmso
concentr
well
cell
seed
cultur
slide
cell
per
chamber
cell
wash
icecold
pb
fix
paraformaldehyd
min
incub
bsapb
wv
cell
wash
cold
pb
three
time
min
cell
subject
immunofluoresc
stain
room
temperatur
wash
cold
pb
three
time
min
cell
examin
use
microscop
equip
digit
camera
system
olympu
tokyo
japan
pseudoconfoc
microscop
apotom
equip
axiocam
mrm
nb
ethanolfix
human
trachea
esophagu
duoden
junction
jejunum
colon
pancrea
liver
ovari
uteru
vagina
sampl
obtain
organ
donor
tissu
sampl
differ
individu
use
prepar
tissu
microarray
tma
healthi
tissu
ethanolfix
colorect
tumor
section
obtain
cancer
surgeri
formalinfix
paraffinembed
human
nsclc
sampl
n
squamou
cell
carcinoma
n
adenocarcinoma
also
obtain
breast
tumor
lung
tumor
tma
formalinfix
tumor
pair
metastasi
pair
adjac
normal
tissu
bought
superbiochip
seoul
south
korea
formalinfix
canin
mammari
tumor
obtain
laboratori
anim
histopatholog
nant
veterinari
school
oniri
immunostain
analysi
perform
tissu
section
tissu
section
deparaffin
endogen
peroxidas
block
incub
section
pb
contain
hydrogen
peroxid
vv
mn
section
block
bsa
wv
min
room
temperatur
follow
incub
ml
biotinyl
rpvl
room
temperatur
ethanolfix
section
ml
biotinyl
rpvl
pb
formalinfix
section
wash
section
twice
pb
indirect
biotinstreptavidin
system
dab
ventana
medic
system
aec
vector
laboratori
detect
kit
use
accord
manufactur
instruct
develop
slide
wash
twice
pb
counterstain
hematoxylin
wash
water
section
dehydr
mount
section
observ
microscop
equip
digit
camera
system
olympu
tokyo
japan
imag
nanozoom
slidescann
hamamatsu
hamamatsu
citi
treatment
glycosidas
section
incub
deparaffin
hydrogen
peroxid
block
u
sialidas
new
england
biolab
u
hour
fresh
enzym
ad
slide
incub
overnight
control
slide
prepar
parallel
correspond
enzym
buffer
sodium
citrat
ph
respect
overnight
incub
slide
wash
twice
pb
block
bsa
wv
stain
rpvl
imag
describ
human
ethanolfix
tissu
tissu
collect
store
law
decemb
concern
resect
human
tissu
death
scientif
investig
reason
approv
research
ethic
committe
appli
sampl
obtain
nant
univers
hospit
center
biolog
resourc
http
relibfr
cancerolog
program
approv
ministri
research
approv
tissu
bank
research
conduct
formalinfix
human
tissu
approv
ministri
research
approv
region
institut
review
board
de
protect
de
personn
cpp
est
region
board
patient
enrol
trial
provid
written
inform
consent
specif
sampl
previous
use
describ
literatur
regard
tissu
microarray
obtain
superbiochip
laboratori
ltd
seoul
korea
compani
certifi
human
materi
remov
collect
donor
prior
consent
payment
whatsoev
made
latter
formalinfix
tissu
canin
breast
tumor
obtain
laboratori
anim
histopatholog
nant
veterinari
school
oniri
case
come
patholog
laboratori
veterinari
teach
hospit
oniri
use
studi
owner
written
consent
approv
oniri
colleg
veterinari
medicin
local
anim
welfar
committe
obtain
prior
inclus
anim
care
use
protocol
adher
european
direct
number
nation
french
regul
du
relatif
la
protect
de
animaux
de
fin
scientifiqu
product
characteris
rpvl
pvl
produc
recombinantli
rpvl
e
coli
purifi
one
step
glcnacagaros
column
final
yield
mg
l
cultur
assay
rabbit
erythrocyt
lectin
display
strong
hemagglutin
activ
concentr
nm
recombin
protein
stabl
demonstr
denatur
temperatur
thermal
shift
analysi
fig
stabil
rpvl
obtain
presenc
glcnaccontain
ligand
like
chitobios
tm
presenc
nonbind
carbohydr
galactos
sucros
confirm
glcnac
bind
activ
specif
recombin
pvl
assay
mammalian
print
array
version
glycan
mostli
mammalian
origin
rpvl
concentr
vari
mg
ml
ml
four
dataset
avail
cfg
site
primscreencod
http
wwwfunctionalglycomicsorg
fluoresc
signal
excel
lowest
concentr
suffici
determin
strong
prefer
oligosaccharid
carri
glcnac
nonreduc
end
fig
lectin
bound
effici
glcnac
present
two
differ
posit
truncat
nglycan
core
pentasaccharid
even
strongli
antenna
extend
polylactosamin
motif
multival
effect
signal
maxim
multiantennari
structur
antenna
lactosamin
repeat
occurr
relat
cancer
progress
polylactosamin
bior
multiantennari
nglycan
termin
bound
fluoresc
signal
higher
ru
one
termin
background
nois
ru
bind
observ
motif
present
bisect
nglycan
presenc
bisect
glcnac
hinder
bind
pvl
neighbor
glcnactermin
antenna
lectin
also
bound
mucin
motif
bear
posit
galnac
residu
type
bound
weakli
chitobios
motif
chitin
lectin
select
anomer
configur
glcnac
sever
oligosaccharid
termin
residu
also
label
epitop
present
human
heparan
sulfat
glcnac
mucin
gastric
gland
glcnac
also
class
iii
mucin
carcinoma
tissu
express
gastric
phenotyp
glycan
array
contain
varieti
oligosaccharid
termin
galnac
pvl
bind
observ
disaccharid
minor
intens
sinc
immobil
wildtyp
pvl
report
bind
sialyl
glycoprotein
bind
oligosaccharid
sialyl
structur
check
inde
weak
bind
may
observ
biantennari
nglycan
termin
epitop
fig
level
fluoresc
close
nois
level
maxium
nevertheless
check
glycan
array
data
obtain
higher
concentr
pvl
mg
ml
bind
sialyloligosaccharid
becam
clearli
visibl
affin
rpvl
variou
glcnaccontain
oligosaccharid
test
free
surfac
bound
protein
use
titrat
microcalorimetri
surfac
plasmon
reson
respect
tabl
fig
affin
glcnac
rang
previous
measur
itc
nativ
pvl
isol
mushroom
kd
quantit
measur
confirm
stronger
affin
structur
glcnac
chitooligosaccharid
dissoci
constant
trisaccharid
lactontrios
good
agreement
observ
valu
measur
method
nglycan
heptasaccharid
present
two
termin
epitop
show
stronger
affin
rpvl
solut
kd
spr
chip
may
due
bival
charact
particular
interact
may
easili
establish
protein
solut
fix
chip
bind
termin
glcnac
residu
biantennari
heptasaccharid
confirm
compar
stoichiometri
linear
five
ligand
per
rpvl
biantennari
heptasaccharid
two
ligand
per
rpvl
thermodynam
bind
also
differ
sinc
biantennari
glycan
one
present
favor
entropi
bind
tabl
could
explain
preorient
two
glcnac
residu
space
crystal
structur
rpvldisaccharid
rpvl
crystal
complex
disaccharid
cap
truncat
polylactosamin
nglycan
structur
solv
resolut
tabl
display
expect
sevenblad
fold
fig
two
present
asymmetr
unit
sinc
similar
chain
describ
overal
structur
recombin
protein
similar
one
describ
previous
wildtyp
pvl
main
differ
presenc
addit
calcium
ion
sinc
rpvl
present
calcium
three
loop
clear
electron
densiti
observ
five
bind
site
site
occupi
glcnac
residu
fig
six
bind
site
termin
glcnac
orient
pvlglcnac
complex
establish
network
hydrogen
bond
galactos
residu
interact
shallow
area
near
glcnac
bind
site
fig
interact
galactos
residu
strong
vari
one
site
nevertheless
one
common
featur
involv
water
molecul
present
site
bridg
disaccharid
atom
oacetyl
glcnac
galactos
backbon
nitrogen
atom
protein
side
chain
conserv
aromat
ring
trp
tyr
stack
glcnac
surfac
fig
water
molecul
play
role
pvl
specif
sinc
galactos
residu
present
axial
hydroxyl
appropri
posit
bind
limit
interact
galactos
residu
pvl
surfac
agreement
limit
chang
affin
observ
compar
glcnac
ligand
nevertheless
orient
reduc
end
protein
ring
perfect
agreement
strong
bind
glycoconjug
surfac
inde
galactos
reduc
label
truncat
glycan
fungal
lectin
end
point
direct
mulitantennari
glycan
glycoprotein
could
easili
display
strong
multival
effect
lung
carcinoma
previous
shown
express
high
level
glcnactermin
glycan
analyz
glycosyltransferas
express
transcriptom
data
pair
lung
adenocarinoma
adjac
normal
tissu
avail
ncbi
databas
found
statist
signific
variat
cancer
healthi
tissu
sever
glycosyltransferas
gene
tabl
particular
express
glcnac
transferas
one
glcnact
respons
synthesi
core
oglycan
structur
respons
synthesi
extend
core
oglycan
structur
found
examin
capac
rpvl
recogn
cell
deriv
human
cancer
tissu
lectin
stain
sever
cell
line
perform
quantit
analyz
use
flow
cytometri
rpvl
strongli
bound
cancer
cell
variou
origin
includ
lung
fig
fig
tabl
breast
prostat
ovari
colon
carcinoma
well
melanoma
presenc
mm
glcnac
bind
rpvl
cell
line
strongli
decreas
indic
specif
involv
carbohydr
bind
site
fig
interestingli
complet
inhibit
achiev
cell
line
immort
normal
lung
cell
line
suggest
rpvl
bind
site
cell
line
may
lower
affin
cancer
cell
line
sinc
glycan
microarray
show
bind
contain
glycan
sialidas
treatment
perform
order
determin
cell
surfac
glycan
could
recogn
lectin
shown
fig
follow
sialidas
treatment
cell
stain
almost
complet
lost
cell
line
much
less
cell
line
result
indic
glycan
repres
major
rpvl
ligand
normal
lung
cell
line
wherea
glcnactermin
structur
may
involv
cancer
cell
line
confirm
involv
glcnactermin
glycan
cancer
cell
show
littl
decreas
rpvl
bind
follow
sialidas
treatment
cell
grown
presenc
inhibitor
sialyltransferas
control
specif
inhibitor
fucosyltransferas
use
fig
latter
compound
affect
bind
either
lectin
mah
rpvl
contrast
decreas
mah
bind
expect
also
rpvl
bind
indic
signific
level
rpvl
bind
cell
due
recognit
epitop
treatment
cell
exo
also
result
major
decreas
rpvl
bind
dosedepend
manner
indic
glcnactermin
glycan
also
recogn
rpvl
cell
line
delin
type
glycan
involv
cell
treat
kifunensin
inhibitor
nglycan
matur
benzylgalnac
inhibitor
oglycosyl
ppmp
inhibitor
glycolipid
synthesi
fig
treatment
three
inhibitor
result
decreas
mah
lectin
indic
termini
present
three
major
type
glycan
likewis
inhibitor
decreas
rpvl
bind
extent
yet
inhibit
rpvl
bind
much
clearer
follow
benzylgalnac
treatment
follow
treatment
collect
data
indic
glcnac
present
oglycan
constitut
major
ligand
rpvl
bind
lung
carcinoma
cell
line
label
healthi
tissu
biotinyl
rpvl
perform
presenc
either
fucos
glcnac
delin
specif
bind
tissu
either
stain
weakli
stain
label
lectin
present
stain
mainli
restrict
epitheli
cell
occasion
macrophag
lung
parenchyma
inhibit
presenc
mm
glcnac
fig
tabl
owev
strong
bind
observ
glandular
compart
stomach
small
intestin
case
partial
inhibit
could
obtain
presenc
mm
glcnac
consist
presenc
mucin
present
termin
glcnac
tissu
previous
describ
sinc
rpvl
label
variou
cancer
cell
line
histochem
stain
healthi
cancer
tissu
perform
shown
fig
strong
label
inhibit
presenc
glcnac
observ
colon
carcinoma
whilst
weak
label
found
adjac
normal
tissu
determin
stain
carcinoma
cell
depend
either
glcnactermin
glycan
tissu
section
canin
breast
carcinoma
treat
either
sialidas
prior
incub
biotinyl
lectin
fig
canin
breast
carcinoma
section
use
sinc
easili
avail
human
breast
carcinoma
section
sinc
tumor
remark
homolog
human
counterpart
enzym
treatment
led
clear
reduct
stain
indic
similar
observ
cell
line
glcnac
involv
lectin
stain
next
analyz
stain
variou
type
lung
breast
carcinoma
rpvl
clear
label
observ
proport
lung
squamou
cell
carcinoma
lung
adenocarcinoma
fig
fig
stain
cancer
cell
rpvl
systemat
higher
normal
surround
cell
posit
tumor
sampl
contrast
none
test
bronchioalveolar
mucoepidermoid
larg
cell
small
cell
carcinoma
test
label
suggest
lectin
could
distinguish
distinct
type
lung
carcinoma
biotinyl
rpvl
appli
breast
tumor
section
fig
major
sampl
appear
posit
although
label
intens
rang
moder
strong
contrast
normal
breast
tissu
adjac
tumor
weak
stain
apic
surfac
canular
epitheli
cell
could
occasion
observ
limit
number
sampl
avail
signific
differ
stain
intens
could
observ
tumor
differ
hormon
receptor
statu
recombin
form
pvl
produc
character
bind
specif
differ
glcnacbind
lectin
accord
specif
pattern
avail
consortium
function
glycom
wheat
germ
agglutinin
wga
tomato
lectin
slt
recogn
termin
glcnac
also
bind
intern
glcnac
chitooligosaccharid
legum
lectin
ulex
europeu
ueaii
griffonia
bandereia
simplicifolia
gslii
display
high
specif
truncat
polylactosaminetyp
nglycan
lectin
present
pili
e
coli
strain
also
recent
shown
specif
recogn
termin
motif
although
rather
low
affin
lectin
closest
specif
pattern
pvl
mushroom
agrocyb
aegerita
relat
protein
ident
also
produc
recombinantli
demonstr
bind
hepatoma
cell
induc
apoptosi
although
inform
provid
bind
event
present
work
open
rout
investig
although
six
bind
site
pvl
highli
specif
termin
glcnac
multival
lectin
display
weak
avid
surfac
may
result
weak
nonspecif
label
tissu
sinc
aim
target
specif
glcnactermin
residu
demonstr
use
sialidas
treatment
andor
competit
low
amount
glcnac
suppress
nonspecif
bind
nevertheless
structur
knowledg
bind
site
allow
engin
modifi
lectin
stronger
select
capac
bind
nonreduc
termin
glcnac
rpvl
marker
interest
cancer
cell
demonstr
howev
rpvl
could
also
diagnost
applic
diseas
exampl
elderli
dementia
distinct
alzheim
diseas
aec
use
peroxidas
substrat
reveal
rpvl
stain
counterstain
perform
use
hematoxylin
slide
imag
use
nanozoom
slide
scanner
digit
magnif
also
shown
inset
b
canin
breast
tumor
section
formalin
fix
treat
glycosidas
stain
ml
rpvlbiot
imag
relat
presenc
agalactonglycan
one
isoform
transferrin
also
agalactoigg
present
serum
patient
rheumatoid
arthriti
previous
detect
pvl
purifi
fungi
use
glycosyltransferas
assay
label
truncat
glycan
fungal
lectin
fast
replic
virus
ebola
viru
sar
coronaviru
also
demonstr
carri
truncat
nglycan
expos
glcnac
residu
previous
propos
truncat
nglycan
observ
ebola
viru
may
due
fast
replic
result
overload
process
machineri
hypothesi
could
also
stand
anarch
develop
cancer
cell
glycosyl
could
poorli
process
howev
could
demonstr
alter
surfac
glycosyl
cancer
cell
correl
modif
glycosyltransferas
express
level
tabl
specif
glycosyl
chang
may
therefor
occur
cell
work
need
investig
mechanim
underli
chang
glycosyl
associ
cancer
demonstr
present
work
rpvl
histochem
stain
could
power
tool
help
patholog
analysi
human
nonsmal
cell
lung
cancer
well
breast
colon
carcinoma
howev
requir
valid
larger
cohort
patient
particularli
larger
scale
analysi
would
permit
establish
correl
prognosi
differ
subgroup
tumor
lectin
proven
interest
specif
lectin
wisteria
japonica
seed
bind
strongli
lung
squamou
cell
carcinoma
therefor
develop
lectin
array
promis
better
detect
glycan
alter
diagnost
purpos
tabl
express
glycosyltransferas
lung
cancer
glycosyltransferas
express
level
extract
transcriptom
analysi
lung
adenocarinoma
adjac
normal
tissu
avail
ncbi
databas
su
l
et
al
bmc
genom
geo
access
gse
thank
biogp
programm
http
biogpsorg
summari
glycosyltransferas
express
trend
tumor
versu
normal
tissu
pair
ttest
use
check
statist
differ
normal
cancer
tissu
express
note
given
pvalu
correct
multipl
test
b
raw
data
left
column
correspond
patient
identif
number
record
dataset
data
avail
dataset
note
mainli
show
galnac
transferas
activ
globosid
synthesi
p
antigen
pdf
tabl
rpvl
bind
variou
cancer
cell
bind
rpvl
determin
flow
cytometri
cancer
cell
line
variou
histolog
origin
describ
materi
method
nd
determin
pdf
tabl
pvl
stain
healthi
tissu
tma
prepar
tissu
variou
origin
come
differ
donor
stain
rpvlbiot
presenc
fucos
nacetyglucosamin
digest
tissu
show
strongest
stain
could
complet
remov
even
presenc
excess
free
glcnac
pdf
